Published in Women's Health Weekly, December 2nd, 2004
"Recent studies indicate that elevation of cellular cAMP levels inhibits ovarian epithelial cancer cell growth.
"In this study, we investigated the effects of elevating cellular cAMP levels on LPA stimulation of OVCAR-3 ovarian cancer cell growth and on LPA stimulation of the serum response factor (SRF) transcription factor," wrote G.H. Nguyen, Georgia Institute of Technology, and colleagues.
"Treatment of OVCAR-3 cells with forskolin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.